Evidence map›Paper›PMID 36559212›Full record

ArticlePharmaceutics2022

Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose.

Antonella Casiraghi, Andrea Gentile, Francesca Selmin, Chiara Grazia Milena Gennari, Eleonora Casagni, Gabriella Roda, Gloria Pallotti, Pierangela Rovellini, Paola Minghetti

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antonella CasiraghiDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.ORCID 0000-0003-3683-8510
Andrea GentileDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.
Francesca SelminDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.ORCID 0000-0002-3680-6124
Chiara Grazia Milena GennariDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.
Eleonora CasagniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.
Gabriella RodaDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.
Gloria PallottiINNOVHUB-Stazioni Sperimentali per l'Industria S.r.l., Area Oli e Grassi, Via Giuseppe Colombo 79, 20133 Milano, Italy.
Pierangela RovelliniINNOVHUB-Stazioni Sperimentali per l'Industria S.r.l., Area Oli e Grassi, Via Giuseppe Colombo 79, 20133 Milano, Italy.
Paola MinghettiDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Via Giuseppe Colombo 71, 20133 Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past 20 years, the interest in Cannabis oily extracts for medicinal use compounded in pharmacy has consistently grown, along with the need to have preparations of adequate quality. Hot maceration (M) is the most frequently used method to compound oily solutions. In this work, we systematically studied the possibility of using an ultrasonic homogenizer and a sonotrode (US) as an alternative extraction method. Oily solutions were prepared using two available varieties of Cannabis for medicinal use, called FM2 and Bedrocan. All preparations resulted with an equivalent content in CBD and THC, with the advantage of a faster process using US. In particular, 10 min sonication at the amplitude optimized for the sonotrode used (2 or 7 mm) provides not statistically different total Δ9-tetrahydrocannabinol (M-FM2: 0.26 ± 0.02 % w/w; US-FM2: 0.19 ± 0.004 % w/w; M-Bedrocan: 1.83 ± 0.17 % w/w; US-Bedrocan: 1.98 ± 0.01 % w/w) and total cannabidiol (M-FM2: 0.59 ± 0.04 % w/w; US-FM2: 0.58 ± 0.01 % w/w) amounts extracted in refined olive oil. It can therefore be confirmed that sonotrode is an efficient and fast extraction technique and its use is without negative consequence on the solvent properties. Despite DSC evidencing that both maceration and sonication modify the T

Indexed as

BedrocanDSCFM2lipophilic volatile carbonyl compoundsoil characterizationoxidized fatty acidssonotrodetocopherol

Identifiers

PMID36559212
PMCPMC9785504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.